CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Manuka Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Manuka Inc
3 Eliezer Vardinon St.
Phone: (646) 233-1454p:646 233-1454 PETAH TIKVA, NY  4959507  Israel Ticker: MNKAMNKA
Business Summary
Manuka, Inc., formerly Artemis Therapeutics, Inc., is focused on offering facial skincare products based on Manuka honey and bee venom. The Company’s products include Face Serum with Manuka Honey and Bee Venom, Face Serum with Enhanced Vitamin C, Day Cream, Nourishing Night Cream with Manuka Honey and Nee Venom, Eye Cream with Manuka Honey and Bee Venom, Face Cleanser Gel and Face Serum. Its Face Serum with Manuka Honey and Bee Venom supports blurring and reduces skin wrinkles. It regenerates skin cells and gives a young and vital appearance to the skin. The bee venom encourages natural skin revival, boosts production of Collagen, enhances skin elasticity and has healing properties for damages skin cells.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director ShimonCitron 67 6/30/2022 6/30/2022
Chief Financial Officer DavidDana 59 7/26/2022 7/26/2022
Chief Operating Officer HaimTabak 75 1/1/2020 1/1/2020

Business Names
Business Name
ARTEMIS THERAPEUTICS INC.
ATMS
INKS
10 additional Business Names available in full report.

General Information
Number of Employees: 4 (As of 12/31/2022)
Outstanding Shares: 112,033,909 (As of 11/20/2023)
Shareholders: 90
Stock Exchange: OTC
Federal Tax Id: 841417774
Fax Number: (302) 655-5049


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024